Pharma companies use TPP to extend their monopolies (Video)


Brand-name prescription drug prices have doubled in the last five years, according to a new report. Now some public health groups and organizations say things could get worse, if the Trans-Pacific Partnership deal delays the introduction of generic drugs. RT America’s Ed Schultz speaks with Lori Wallach, director of Public Citizen’s Global Trade Watch, about how the new deal could lead to even higher costs of medication.


Submit a correction >>

Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Your privacy is protected. Subscription confirmation required.


Comments
comments powered by Disqus

Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Your privacy is protected. Subscription confirmation required.

RECENT NEWS & ARTICLES

Get the world's best independent media newsletter delivered straight to your inbox.
x

By continuing to browse our site you agree to our use of cookies and our Privacy Policy.